Poverty is a leading cause of death

Poverty is one of the leading causes of death in the United States, according to a recent study published in JAMA

Poverty was associated with 183,000 deaths in the United States in 2019 among people 15 years and older, according to the paper, titled “Novel Estimates of Mortality Associated With Poverty in the US,” by University of California-Riverside (UCR) researchers.

The estimate, which is considered conservative because it is from the year prior to the COVID-19 pandemic when deaths spiked, is possibly the first to focus on the associated death rate of poverty in the United States, the researchers wrote. 

The figures put poverty as the fourth greatest cause of death in the nation––above obesity, diabetes, drug overdoses, suicides, firearms, homicides and other potential causes. 

“Poverty kills as much as dementia, accidents, stroke, Alzheimer's, and diabetes,” lead author David Brady, PhD, a UCR professor of public policy, said in a statement. “Poverty silently killed 10 times as many people as all the homicides in 2019. And yet, homicide firearms and suicide get vastly more attention.” 

The study also found that people living in poverty, with incomes less than 50% of the U.S. median income, have about the same survival rates as other groups and people with more resources and adequate incomes until they age into their 40s, when they start dying at significantly higher rates. The study has several implications when it comes to different demographics, such as social policies that can reduce poverty and lower mortality. 

“Because certain ethnic and racial minority groups are far more likely to be in poverty, our estimates can improve understanding of ethnic and racial inequalities in life expectancy,” researchers wrote. 

In addition, the research underscores the huge economic impact of high mortality rates due to poverty.

“If we had less poverty, there'd be a lot better health and well-being, people could work more, and they could be more productive,” Brady said. “All of those are benefits of investing in people through social policies.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.